Northern Trust Corp Rezolute, Inc. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Rezolute, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 94,961 shares of RZLT stock, worth $365,599. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94,961
Previous 96,957
2.06%
Holding current value
$365,599
Previous $470,000
3.83%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding RZLT
# of Institutions
76Shares Held
44.6MCall Options Held
201KPut Options Held
2.8K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$43.4 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.86MShares$11 Million0.69% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$10.8 Million2.6% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$9.72 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$8.94 Million0.0% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $149M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...